schestowitz@joindiaspora.com
Dr. Roy Schestowitz

#UPC is not even possible, but #TeamUPC pretends that it's already here. This is part of the fake news trend. https://www.pinsentmasons.com/out-law/analysis/how-regulation-competition-law-upc-could-impact-biosimilar-medicines see http://techrights.org/2021/08/19/captured-media-telling-lies/

How regulation, competition law and the UPC could impact biosimilar medicines

Streamlined regulatory pathways, the application of competition law and a new court system in Europe are all likely to shape the way in which new biosimilar medicines will enter the market in the years ahead.

There are no comments yet.